Clinical Research On The Treatment Of Jianpi Liqi Hexue Of Spleen Deficiency Liver Depression Of Ulcerative Colitis

Objective:To explore through clinical observation of Jianpi Liqi Hexue Treatment of Spleen deficiency Liver depression of ulcerative colitis for the mechanism and the value. Methods:The clinical study will meet the requirements of 42 cases of ulcerative colitis patients were randomly divided into two groups:the experience of Diagnosis and Prescription mucosa partial control group:Oral Salicylazosulfapyridine(SASP).For a course of treatment(20d) Evaluation observed after treatment.Results:In the treatment group and the control group respectively of the total efficiency of 85.71%,57.14%,and there is a significant difference(P＜0.05).The total efficiency of intestinal mucosa were 80.95%,52.38%,a significant difference(P＜0.05).Conclusion:Jianpi Liqi Hexue can significantly improve the patient's clinical symptoms and intestinal mucosa in the overall differentiation on the basis of the intestinal mucosa with local Syndrome,and Differential Treatment can be further perfected.